These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2051320)

  • 1. Determination of sematilide in plasma by high-performance liquid chromatography.
    Dancik S; Koziol T; Nisperos E; Woolf E
    J Pharm Sci; 1991 Feb; 80(2):157-9. PubMed ID: 2051320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay for sematilide in plasma using solid-phase extraction microcolumn technology.
    Laganière S; Goernert L; Beatch G
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):191-5. PubMed ID: 7858714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
    Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
    J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of sematilide in renal failure.
    Shi J; Ripley E; Gehr TW; Sica DA; Dandekar KA; Hinderling PH
    J Clin Pharmacol; 1996 Feb; 36(2):131-43. PubMed ID: 8852389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and dynamics of sematilide.
    Shi J; Lasser T; Koziol T; Hinderling PH
    Ther Drug Monit; 1995 Oct; 17(5):437-44. PubMed ID: 8585104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.
    Dutcher JS; Strong JM
    Clin Chem; 1977 Jul; 23(7):1318-20. PubMed ID: 872378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
    Zhong D; Blume H
    Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High performance liquid chromatography of procainamide and N-acetylprocainamide in human blood plasma.
    Raphanaud D; Borensztejn M; Dupeyron JP; Guyon F
    Ther Drug Monit; 1986; 8(3):365-7. PubMed ID: 2428144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detection.
    Plomp TA; Boom HT; Maes RA
    J Anal Toxicol; 1986; 10(3):102-6. PubMed ID: 3724068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F; Alballa RS; Mehvar R; Lemko CH
    Ther Drug Monit; 1988; 10(1):91-6. PubMed ID: 2453956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic method for the radiometric determination of [14C] bucromarone in human plasma utilizing non-radiolabeled bucromarone as an internal standard.
    Everett DW; Foley JE; Singhvi SM; Weinstein SH; Warrington SJ
    J Chromatogr; 1989 Feb; 487(2):365-73. PubMed ID: 2723003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative kinetics of sematilide in four species.
    Hinderling PH; Dilea C; Koziol T; Millington G
    Drug Metab Dispos; 1993; 21(4):662-9. PubMed ID: 8104126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of an arylacetamide antiarrhythmic in rat blood and tissues using reversed-phase high-performance liquid chromatography.
    Walker ML; Wall RA; Walker MJ
    J Chromatogr B Biomed Appl; 1996 Jan; 675(2):257-63. PubMed ID: 8852713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias.
    Wong W; Pavlou HN; Birgersdotter UM; Hilleman DE; Mohiuddin SM; Roden DM
    Am J Cardiol; 1992 Jan; 69(3):206-12. PubMed ID: 1731461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis for procainamide and N-acetyl procainamide in plasma or serum by high-performance liquid chromatography.
    Rocco RM; Abbott DC; Giese RW; Karger BL
    Clin Chem; 1977; 23(4):705-8. PubMed ID: 844165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs.
    Lagerström PO; Persson BA
    J Chromatogr; 1978 Feb; 149():331-40. PubMed ID: 649734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sematilide. CK 1752, CK 1752A, ZK 110516.
    Drugs R D; 1999 Apr; 1(4):322-6. PubMed ID: 10566054
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitive method for determination of nicorandil in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Tanikawa M; Uzu M; Ohsawa Y; Fukushima M
    J Chromatogr; 1993 Jul; 617(1):163-7. PubMed ID: 8376532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.